Evolent HealthEVH
Market Cap: $3.55B
About: Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
Employees: 4,700
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
38% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 74
3.32% more ownership
Funds ownership: 108.31% [Q1] → 111.63% (+3.32%) [Q2]
3% less funds holding
Funds holding: 250 [Q1] → 243 (-7) [Q2]
13% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 53
40% less capital invested
Capital invested by funds: $4.1B [Q1] → $2.48B (-$1.62B) [Q2]
43% less funds holding in top 10
Funds holding in top 10: 7 [Q1] → 4 (-3) [Q2]
58% less call options, than puts
Call options by funds: $10.5M | Put options by funds: $25.1M
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Truist Securities Jailendra Singh 52% 1-year accuracy 17 / 33 met price target | 8%upside $33 | Buy Maintained | 27 Aug 2024 |
RBC Capital Sean Dodge 56% 1-year accuracy 24 / 43 met price target | 38%upside $42 | Outperform Reiterated | 26 Aug 2024 |
JP Morgan Anne Samuel 57% 1-year accuracy 8 / 14 met price target | 47%upside $45 | Overweight Maintained | 19 Aug 2024 |
JMP Securities Constantine Davides 32% 1-year accuracy 7 / 22 met price target | 2%upside $31 | Market Outperform Maintained | 9 Aug 2024 |
Truist Securities Jailendra Singh 52% 1-year accuracy 17 / 33 met price target | 8%upside $33 | Buy Upgraded | 9 Aug 2024 |
Financial journalist opinion
Based on 4 articles about EVH published over the past 30 days